|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Structure, function and expression on blood and bone marrow cells of the urokinase - type plasminogen activator receptor, uPAR 显示文摘 | Plesner T Behrendt N Ploug M | 1997 | Stem Cells1997，15，6： | 1 |
| 2 | Expression of the receptot fobr urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue显示文摘 | Plesner T Ralfkiaer E Wittrup M | 1994 | Am J Clin Pathol1994，102，6： | 1 |
| 3 | Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR显示文摘 | Plesner T Behrendt N Ploug M | 1997 | Stem Cells1997，15，6： | 1 |
| 4 | Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the region of southern Denmark 显示文摘 | Christensen JH Abildgaard N Plesner T | 2007 | Cancer Genet Cytogenet2007，174，2： | 1 |
| 5 | Daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: updated results of a phase 1/2 study ( GEN503 ) 显示文摘 | Plesner T Arkenau HT Gimsing P | 2015 | Blood2015，126，23： | 1 |
| 6 | A soluble form of the glycolipid anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria显示文摘 | Ploug M Eriksen J Plesner T | 1992 | Eur J Biochem1992，208，2： | 1 |
| 7 | Allergic mucocutaneous reactions to Japanese encephalitis vaccines显示文摘 | Plesner AM Ronne T | 1997 | Vaccine1997，15，： | 1 |
| 8 | Soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria 显示文摘 | Ploug M Eriksen J Plesner T | 1992 | Eur J Biochem1992，208，2： | 1 |
| 9 | Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue显示文摘 | Plesner T Ralfkiaer E Wittrup M | 1994 | Am J Clin Pathol1994，102，6： | 1 |
| 10 | A phase 2 study of SRT501(resveratrol) with bortezomib for patients with relapsed and orrefractory multiple myeloma 显示文摘 | Popat R Plesner T Davies F | 2013 | Br J Haematol2013，160，5： | 1 |
| 11 | Targeting CD38 with daratumumabmonotherapy in multiple myeloma显示文摘 | Lokhorst H M Plesner T Laubach J P | | N Engl J Med0，373，13： | 1 |
| 12 | Structure, function and expression On blood and bone marrow cells of the urokinase-type plasminogen activator receptor,uPAR 显示文摘 | Plesner T behrendt N Ploug M | 1997 | Stem Cells1997，15，6： | 1 |
| 13 | Phase I/11dose-escalation study of daratumumab in patients with relapsedor refractory multiple myeloma 显示文摘 | Lokhorst HM Plesner T Gimsing P | 2013 | J Clin Oncol2013，31，15： | 1 |
| 14 | Structure, Func- tion and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR 显示文摘 | PLESNER T BEHRENDT N PLOUG M | 1997 | Stem cells1997，15，6： | 1 |
| 15 | Hu Max-CD20, a novelfully human anti CD20 mono- clonal antibody; Results of a phase I/II trial in re- lapsed or refractory follicular non-Hodgkin's lym phoma显示文摘 | Hagenbeek A Plesner T Johnson P | 2005 | Blood2005，106，4： | 1 |
| 16 | HuMax-CD20, a novel fully human anti-CD20 monoclonal antibody: results of a phase I/II trial in relapsed or refractory follicular non-Hodgkin's lymphoma 显示文摘 | Hagenbeek A Plesner T Johson P | 2005 | Blood2005，106，： | 1 |
| 17 | A physical mechanism for coupling bone resorption and formation in adult human bone显示文摘 | Andersen TL Sondergaard TE Skorzynska KE Dagnaes-Hansen F Plesner TL Hauge EM Plesner T Delaisse JM | | 0，，： | 1 |
| 18 | Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7in multiple myeloma显示文摘 | van de Donk NW Moreau P Plesner T | 2016 | Blood2016，127，： | 1 |
| 19 | HuMax-CD20,a novel fully human anti-CD20 monoclonal antibody:Results of a phase I/II trial in relapsed or refractory follicular non-Hodgkin′s lymphoma显示文摘 | Hagenbeek A Plesner T Johnson P | 2005 | Blood2005，106，4： | 1 |
| 20 | Targeting CD38 with daratumumab monotherapy in multiple myeloma 显示文摘 | Lokhorst HM Plesner T Laubach JP | 2015 | N Engl J Med2015，373，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员